Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Results and related outcomes for the trial were posted, including Recurrence-free Survival, Overall Survival, DMFS, and CTCAE v5.0 adverse events, and a PDF of the Study Protocol and Statistical Analysis Plan was provided. The entries detailing previous result estimation text were removed.
    Difference
    2%
    Check dated 2026-06-20T05:54:45.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    New recruitment status note 'No longer looking for participants' and guidance sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the 'Intervention / Treatment' heading was standardized to 'Intervention/Treatment'. The footer revision label was updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:56:24.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a small maintenance/update to the page metadata rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-06-05T22:19:01.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page’s revision history now shows a new version, v3.5.4, replacing the previous v3.5.3. This update signals a new publication of the page and primarily affects metadata rather than the study content.
    Difference
    0.1%
    Check dated 2026-05-15T14:42:07.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a behind-the-scenes release rather than changes to the clinical trial details presented.
    Difference
    0.1%
    Check dated 2026-04-24T06:27:43.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:53.000Z thumbnail image

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.